One year later, another group showed that low doses of warfarin efficiently block Axl signaling in tumor cells, preventing the progression and metastasis of pancreatic cancer by reversing EMT transition, tumor migration, chemoresistance, and intratumoral microvessel density [47]. This evidence concerns the gene AXL and neoplasm.